Classification of scaffold-hopping approaches

被引:273
作者
Sun, Hongmao [1 ]
Tawa, Gregory [1 ]
Wallqvist, Anders [1 ]
机构
[1] US Army Med Res & Mat Command, Biotechnol HPC Software Applicat Inst, Telemed & Adv Technol Res Ctr, Frederick, MD 21702 USA
关键词
CAMBRIDGE STRUCTURAL DATABASE; RECEPTOR ANTAGONISTS; BIOLOGICAL-ACTIVITIES; KINASE INHIBITORS; CRYSTAL-STRUCTURE; DRUG DISCOVERY; CELL-DIVISION; TURN MIMETICS; DESIGN; ANGIOTENSIN;
D O I
10.1016/j.drudis.2011.10.024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The general goal of drug discovery is to identify novel compounds that are active against a preselected biological target with acceptable pharmacological properties defined by marketed drugs. Scaffold hopping has been widely applied by medicinal chemists to discover equipotent compounds with novel backbones that have improved properties. In this article we classify scaffold hopping into four major categories, namely heterocycle replacements, ring opening or closure, peptidomimetics and topology-based hopping. We review the structural diversity of original and final scaffolds with respect to each category. We discuss the advantages and limitations of small, medium and large-step scaffold hopping. Finally, we summarize software that is frequently used to facilitate different kinds of scaffold-hopping methods.
引用
收藏
页码:310 / 324
页数:15
相关论文
共 50 条
  • [11] Scaffold-hopping from aminoglycosides to small synthetic inhibitors of bacterial protein biosynthesis using a pseudoreceptor model
    Urbanek, Dorota A.
    Proschak, Ewgenij
    Tanrikulu, Yusuf
    Becker, Steffi
    Karas, Michael
    Schneider, Gisbert
    MEDCHEMCOMM, 2011, 2 (03) : 181 - 184
  • [12] Scaffold-Hopping Potential of Fragment-Based De Novo Design: The Chances and Limits of Variation
    Krueger, Bjoern A.
    Dietrich, Axel
    Baringhaus, Karl-Heinz
    Schneider, Gisbert
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2009, 12 (04) : 383 - 396
  • [13] Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase 11α-inhibiting Anticancer Agents
    Priyadarshani, Garima
    Nayak, Anmada
    Amrutka, Suyog M.
    Das, Sarita
    Guchhait, Sankar K.
    Kundu, Chanakya N.
    Banerjee, Uttam C.
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (12): : 1056 - 1061
  • [14] Scaffold-hopping of bioactive flavonoids: Discovery of aryl-pyridopyrimidinones as potent anticancer agents that inhibit catalytic role of topoisomerase IIα
    Priyadarshani, Garima
    Amrutkar, Suyog
    Nayak, Anmada
    Banerjee, Uttam C.
    Kundu, Chanakya N.
    Guchhait, Sankar K.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 122 : 43 - 54
  • [15] Scaffold hopping and redesign approaches for quinazoline based urea derivatives as potent VEGFR-2 inhibitors
    Hadi, Soha R. Abd El
    Lasheen, Deena S.
    Soliman, Dalia H.
    Elrazaz, Eman Z.
    Abouzid, Khaled A. M.
    BIOORGANIC CHEMISTRY, 2020, 101
  • [16] Discovery of potential Toxoplasma gondii CDPK1 inhibitors with new scaffolds based on the combination of QSAR and scaffold-hopping method with in vitro validation
    Zhang, Pengyi
    Jia, Lipei
    Tian, Yafei
    Xi, Lili
    Duan, Ruizhi
    Chen, Ximing
    Xiao, Jianxi
    Yao, Xiaojun
    Lan, Jingfeng
    Li, Shuyan
    CHEMICAL BIOLOGY & DRUG DESIGN, 2020, 95 (05) : 476 - 484
  • [17] Design of thiamine analogues for inhibition of thiamine diphosphate (ThDP)-dependent enzymes: Systematic investigation through Scaffold-Hopping and C2-Functionalisation
    Chan, Alex H. Y.
    Ho, Terence C. S.
    Irfan, Rimsha
    Hamid, Rawia A. A.
    Rudge, Emma S.
    Iqbal, Amjid
    Turner, Alex
    Hirsch, Anna K. H.
    Leeper, Finian J.
    BIOORGANIC CHEMISTRY, 2023, 138
  • [18] Searching for Dual Inhibitors of the MDM2-p53 and MDMX-p53 Protein-Protein Interaction by a Scaffold-Hopping Approach
    Zaytsev, Andrey
    Dodd, Barry
    Magnani, Matteo
    Ghiron, Chiara
    Golding, Bernard T.
    Griffin, Roger J.
    Liu, Junfeng
    Lu, Xiaohong
    Micco, Iolanda
    Newell, David R.
    Padova, Alessandro
    Robertson, Graeme
    Lunec, John
    Hardcastle, Ian R.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 86 (02) : 180 - 189
  • [19] Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challenges
    Mishra, Anshul
    Thakur, Amandeep
    Sharma, Ram
    Onuku, Raphael
    Kaur, Charanjit
    Liou, Jing Ping
    Hsu, Sung-Po
    Nepali, Kunal
    EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (11) : 1355 - 1381
  • [20] Recent Advances in Scaffold Hopping
    Hu, Ye
    Stumpfe, Dagmar
    Bajorath, Juergen
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (04) : 1238 - 1246